Bravecto, a chewable flea and tick prevention that is produced by Merk Animal Health, has been highlighted in recent news as potentially being unsafe for pets. Merk Animal Health has released a statement including the safety research that has been done on Bravecto.
“As you may be aware, fleas and ticks are not just a nuisance, but also pose animal and human health risks, as they can transmit disease (including Lyme disease, Rocky Mountain Spotted Fever, bartonellosis and others).
That’s why it’s critical to protect pets from these parasites and keep them out of homes. Bravecto is the first and only treatment that has been shown to quickly and effectively kill fleas and multiple tick species for 12 weeks in a single dose. It also is effective for eight weeks against Amblyomma americanum ticks.
More than 34 million doses of Bravecto have been dispensed in 60 countries. We are pleased with the overwhelmingly positive responses we’ve had from veterinarians and pet owners from throughout the world about the benefits of Bravecto.” –Merk Animal Health